-

AHN’s Premier Medical Associates Expands Use of Innovative, Clinical-decision Support Software

MedsEngine’s hypertension module will aid Premier clinicians in the care of hypertensive patients

DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine announced today that Allegheny Health Network’s (AHN) Premier Medical Associates has further expanded its use of its clinical decision support software solution, also known as MedsEngine, to include its hypertension module.

MedsEngine, which is integrated with AHN’s Epic electronic health record (EHR) system, delivers real-time, personalized medication recommendations which aids providers in making the best possible treatment decisions in the care of patients with chronic diseases.

According to the CDC, 119.9 million adults in the U.S., or approximately 48% of the population, have high blood pressure, also known as hypertension. However, only about 27 million adults have their condition under control.

Last year, AHN announced the first live integration between MedsEngine and Epic including specialized modules for patients with Type 2 Diabetes and/or high cholesterol. This latest integration allows primary care clinicians at Premier to utilize MedsEngine software in caring for hypertensive patients.

“MedsEngine has been pleased to assist Premier for the last several years in improving the health outcomes of thousands of their patients living with chronic conditions,” said Douglas Romer, MD, chief medical officer, MedsEngine. “With this latest addition of the hypertension module, Premier caregivers will be even better equipped to care for the many patients who struggle to manage high blood pressure.”

To learn more about MedsEngine, visit www.medsengine.com.

About MedsEngine: MedsEngine develops EHR-integrated clinical decision support applications that generate real-time, personalized, evidence-based medication recommendations for Hypertension, Cholesterol Management, Type 2 Diabetes, and Heart Failure. For more information, visit www.medsengine.com.

Contacts

hello@medsengine.com

Industry:

MedsEngine

Release Versions
English

Contacts

hello@medsengine.com

More News From MedsEngine

MedsEngine Helps Medical Practices Unlock $30,000 Per Provider in Additional Annual Revenue

DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine, a leader in chronic disease management software, announced today that medical practices using its Cholesterol and Type 2 Diabetes modules could generate up to $30,000 in additional annual revenue. This estimate is based on a typical patient panel of 2,000 and leverages national averages and published financial data related to these chronic conditions. “Using MedsEngine is a win-win for providers and patients,” said Dr. Doug Romer, Chief Medical Officer...

MedsEngine Achieves High Blood Pressure Control In Less Than Two Office Visits

DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine LLC, a provider of chronic disease management software, presented its findings on blood pressure control to the European Society of Hypertension in Milan, Italy, May 23-26, 2025. The findings showed that users of the MedsEngine Hypertension module were able to achieve high BP control rates, to a goal of <140/90, in less than two office visits. These results build on earlier presentations at the European Society of Cardiology Congress in 2023 and 2024...

MedsEngine Achieves SOC 2 Type II Certification: Reinforcing Our Commitment to Data Security

DAYTON, Ohio--(BUSINESS WIRE)--MedsEngine, a provider of chronic disease management software, is proud to announce that it has successfully attained SOC 2 Type II certification. This certification, awarded by the American Institute of Certified Public Accountants (AICPA), is a rigorous audit that evaluates a company's controls relevant to security, availability, processing integrity, confidentiality, and privacy. Dr. Doug Romer, CMO, stated, “this milestone underscores MedsEngine’s continued co...
Back to Newsroom